CVE & CISA-KEV Catalog

CVE-2026-17583

HIGH
8.4
CVSS v3
NVD

Description

The affected Thermo Fisher Applied Biosystems Genetic Analyzers are vulnerable because .fsa/.hid output files can be edited. An attacker could tamper with these files, altering DNA data and resulting in inaccurate DNA test outcomes.

How to fix

Remediation Available
applied biosystems 3500\/3500xl series data collection softwareNVD
Affected:< 4.0.3Fixed in:4.0.3CVE-2026-17583derived from NVD
applied biosystems 3730\/3730xl series data collection softwareNVD
Affected:< 5.0.3Fixed in:5.0.3CVE-2026-17583derived from NVD
applied biosystems seqstudio flex series instrument softwareNVD
Affected:< 1.2.1Fixed in:1.2.1CVE-2026-17583derived from NVD
applied biosystems seqstudio genetic analyzer data collection softwareNVD
Affected:< 1.2.6Fixed in:1.2.6CVE-2026-17583derived from NVD
genemapper id-xNVD
Affected:< 1.7.4Fixed in:1.7.4CVE-2026-17583derived from NVD

TridentStack Control can deploy fixes like this automatically across your Windows, macOS, and Linux fleet. See how it works

Remediation is compiled from vendor and distribution security advisories. Always confirm against the linked source for your exact version and platform.

CVSS v3 Vector

Exploitability

Attack VectorLocal
Attack ComplexityLow
Privileges RequiredNone
User InteractionNone
ScopeUnchanged

Impact

ConfidentialityHigh
IntegrityHigh
AvailabilityHigh

CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Exploit Intelligence

0.21%probability of exploitation in 30 days
10thpercentile

Low risk: more likely to be exploited than 10% of all known CVEs.

References

Related Vulnerabilities

Other CWE-353 vulnerabilities, ordered by exploit likelihood. View all

CVESeverityCVSSEPSSExploitedFix
CVE-2021-28545High8.12.3%--
CVE-2021-28546Medium6.51.4%--
CVE-2019-10943High7.51.0%-Fix
CVE-2020-10124High7.10.7%--
CVE-2020-7878Critical9.80.7%--
CVE-2020-7808High8.70.7%--

Common questions

How do I fix CVE-2026-17583?

Published advisories record a fix for 5 affected products. The "How to fix" section on this page lists the fixed version and source advisory for each one, so apply the entry matching what you actually run.

Is CVE-2026-17583 being actively exploited?

Not that we know of. CVE-2026-17583 is not in the CISA Known Exploited Vulnerabilities catalog. Its EPSS score of 0.21% is the estimated probability that it will be exploited in the next 30 days. That is higher than 10% of all scored CVEs.

How severe is CVE-2026-17583?

CVE-2026-17583 has a CVSS v3 base score of 8.4, rated high. CVSS rates the technical impact if the vulnerability is exploited, not how likely that is, so weigh it alongside the exploit-prediction score when you decide what to patch first.

What does CVE-2026-17583 affect?

Published advisories record a fix for applied biosystems 3500\/3500xl series data collection software (NVD), applied biosystems 3730\/3730xl series data collection software (NVD), applied biosystems seqstudio flex series instrument software (NVD), applied biosystems seqstudio genetic analyzer data collection software (NVD), and 1 more. Only products with a sourced advisory are listed, so treat this as what we can cite rather than a complete inventory.

Embed a live status badge for CVE-2026-17583
CVE-2026-17583 severity badge

Markdown

[![CVE-2026-17583](https://tridentstack.com/cve/badge/CVE-2026-17583.svg)](https://tridentstack.com/cve/CVE-2026-17583)

HTML

<a href="https://tridentstack.com/cve/CVE-2026-17583"><img src="https://tridentstack.com/cve/badge/CVE-2026-17583.svg" alt="CVE-2026-17583"></a>

Find and fix vulnerabilities across your fleet

TridentStack Control continuously scans your Windows, macOS, and Linux fleet for known vulnerabilities, prioritizes them by severity and active exploitation, and patches them automatically.

See how it worksStart freeThis CVE lookup is free and always will be.

This product uses NVD data but is not endorsed or certified by the NVD. EPSS scores courtesy of FIRST.org (https://www.first.org/epss). Source: CISA KEV Catalog. Data as of 2026-08-26.